Search
Search Results
##search.searchResults.foundPlural##
-
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4880PDF: 4001HTML: 385 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4769PDF: 1844HTML: 1451 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2771PDF: 1859HTML: 745 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
4280PDF: 1266HTML: 2140Fig.1: 256Fig. 2: 152Table 1: 266Table2: 295Table 3: 288 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3903PDF: 2691HTML: 1732 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3984PDF: 1761HTML: 123 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2748PDF: 941HTML: 9092Efremov 1: 291Efremov 2: 262 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1608PDF: 913HTML: 3158 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3794PDF: 1829HTML: 5995Fig1-Ag-Pil: 302Ag-Pil Fig.2: 297 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3465PDF: 1151HTML: 2611 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
6038PDF: 1643HTML: 1690Untitled: 302 -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
4814PDF: 1787HTML: 4381Tables and Images: 324 -
OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT
1704HTML: 436PDF: 1051Suppl. Files: 540 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1341PDF: 671HTML: 6947 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1823PDF: 1184HTML: 532 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3352PDF: 984HTML: 7329Kost Fig1: 252Kost Fig 2: 231Kost Fig3: 252Kost Fig 4: 268Kost Fig5: 255Kost fig 6: 251 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2567PDF: 1997HTML: 203 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
8031PDF: 2553HTML: 2185Table 1.: 296Table 2.: 320Table 3.: 278Table 4.: 287 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3660PDF: 908HTML: 3046Figure 1a and 1b: 230Figure 2: 247Figure 3: 233Figure 4: 225Figure 5: 225Tables 1-5: 201 -
REAL-WORLD OUTCOME IN THE PRE-CAR-T ERA OF MYELOMA PATIENTS QUALIFYING FOR CAR-T CELL THERAPY Real-world Assessment of Myeloma Patients as Candidates for CAR-T Therapy
1805PDF: 837HTML: 1526 -
IS THERE A ROLE FOR MINIMAL RESIDUAL DISEASE MONITORING IN FOLLICULAR LYMPHOMA IN THE CHEMO-IMMUNOTHERAPY ERA?
3698PDF: 1396HTML: 2429Fi.1 Gritti.Rambaldi: 282 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2901PDF: 1038HTML: 624 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3129PDF: 1491HTML: 3750Untitled: 286Untitled: 282Untitled: 235 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1935PDF: 968HTML: 489Fig1: 302Fig.2: 345Fig. 3: 264Fig. 5: 291Fig. 4: 299
1 - 39 of 39 items







